New York Office | firstname.lastname@example.org | 212.257.6024
Chris LiPuma is an Executive Director at Torreya. He works with companies raising structured debt and equity, and selling and securitizing royalties. Chris also works on strategic transactions, including asset divestitures, recapitalizations, restructurings, mergers, and company sales.
Chris’ career has focused on advising and investing in late-stage life sciences companies. Before joining Torreya in 2018 Chris ran business development at Kastle Therapeutics, a private equity backed specialty pharmaceutical company. Prior to Kastle, Chris was a member of the OrbiMed Advisors structured investments team and an investment professional at Healthcare Royalty Partners. Chris invested in a range of transactions including royalty monetizations, public and private debt, growth equity investments, and off-balance sheet financings for larger pharmaceutical companies. Chris began his career at Leerink Partners on the investment banking team.
Chris holds a B.A. from Hamilton College in economics and communication.